Research programme: Id protein modulators - AngioGenexAlternative Names: AGX 1053; AGX 51; AGX 8
Latest Information Update: 08 Jul 2011
At a glance
- Originator Memorial Sloan-Kettering Cancer Center
- Developer AngioGenex
- Class Antisense DNA; Peptides; Small molecules
- Mechanism of Action Angiogenesis inhibitors; Inhibitor of differentiation protein 1 inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Cancer; Eye disorders